Page last updated: 2024-11-05

16-hydroxypalmitic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

16-Hydroxypalmitic acid is a long-chain fatty acid with a hydroxyl group at the 16th carbon atom. It is a naturally occurring compound found in various plants and animals. Research on 16-hydroxypalmitic acid is primarily focused on its role in biological processes, including:

* **Antioxidant activity:** Studies suggest that 16-hydroxypalmitic acid may have antioxidant properties due to its hydroxyl group, which can scavenge free radicals.
* **Regulation of lipid metabolism:** It is involved in the regulation of lipid metabolism and may play a role in the biosynthesis and degradation of lipids.
* **Cellular signaling:** Research suggests that 16-hydroxypalmitic acid may act as a signaling molecule in cells, mediating cellular responses to various stimuli.
* **Potential therapeutic applications:** Due to its biological activities, 16-hydroxypalmitic acid has been investigated for its potential therapeutic applications in conditions such as inflammation, cardiovascular disease, and cancer.

While the synthesis of 16-hydroxypalmitic acid has been achieved through chemical methods, its biological synthesis pathway is not fully understood. Further research is ongoing to elucidate its detailed biological functions and potential therapeutic implications.'

16-hydroxyhexadecanoic acid : An omega-hydroxy-long-chain fatty acid that is hexadecanoic acid (also known as palmitic acid) which is substituted at position 16 by a hydroxy group. It is a key monomer of cutin in the plant cuticle. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10466
CHEMBL ID4281719
CHEBI ID55328
SCHEMBL ID153053
MeSH IDM0175032

Synonyms (50)

Synonym
palmitic acid, 16-hydroxy-
nsc159292
.omega.-hydroxypalmitic acid
506-13-8
juniperic acid
nsc-159292
16-hydroxyhexadecanoic acid
16-hydroxypalmitic acid
hexadecanoic acid, 16-hydroxy-
LMFA01050051
juniperinic acid
16-hydroxy-hexadecanoic acid
16-hydroxyhexadecanoic acid, 98%
C18218
BMSE000700
AKOS005068207
16-oh 16:0
omega-hydroxypalmitic acid
CHEBI:55328
H0675
A828204
16y ,
nsc 159292
7ipp3u0f3i ,
unii-7ipp3u0f3i
einecs 208-028-7
FT-0607251
16-hydroxy hexadecanoic acid
SCHEMBL153053
DTXSID6060133
mfcd00002750
omega hydroxy hexadecanoate (n-c16:0)
hydroxy hexadecanoate
omega-hydroxy hexadecanoic acid
hydroxy hexadecanoic acid
16-hydoxy hexadecanoate
omega hydroxy hexadecanoic acid
16-hydoxy hexadecanoic acid
omega hydroxy hexadecanoate
omega-hydroxy hexadecanoate
w-hydroxy hexadecanoate
w-hydroxy hexadecanoic acid
16-hydroxyhexadecanoicacid
CS-0068707
AS-47314
Q27124231
AMY37955
SY057066
CHEMBL4281719
F13220
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
omega-hydroxy-long-chain fatty acidA omega-hydroxy-fatty acid with a chain length ranging from C13 to C22.
hydroxypalmitic acidA hydroxy fatty acid that is palmitic (hexadecanoic) acid substituted with one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Free fatty acid receptor 1Homo sapiens (human)EC50 (µMol)20.89300.00030.73698.8000AID1416221
Free fatty acid receptor 4Homo sapiens (human)EC50 (µMol)1.69820.04372.35477.5858AID1416220
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (29)

Processvia Protein(s)Taxonomy
phospholipase C-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationFree fatty acid receptor 1Homo sapiens (human)
insulin secretionFree fatty acid receptor 1Homo sapiens (human)
negative regulation of interleukin-1 beta productionFree fatty acid receptor 1Homo sapiens (human)
glucose homeostasisFree fatty acid receptor 1Homo sapiens (human)
positive regulation of calcium ion transportFree fatty acid receptor 1Homo sapiens (human)
response to fatty acidFree fatty acid receptor 1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
ligand-gated ion channel signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of insulin secretionFree fatty acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
negative regulation of cytokine productionFree fatty acid receptor 4Homo sapiens (human)
inflammatory responseFree fatty acid receptor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 4Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationFree fatty acid receptor 4Homo sapiens (human)
regulation of glucose transmembrane transportFree fatty acid receptor 4Homo sapiens (human)
negative regulation of interleukin-1 beta productionFree fatty acid receptor 4Homo sapiens (human)
ghrelin secretionFree fatty acid receptor 4Homo sapiens (human)
negative regulation of apoptotic processFree fatty acid receptor 4Homo sapiens (human)
positive regulation of osteoblast differentiationFree fatty acid receptor 4Homo sapiens (human)
negative regulation of inflammatory responseFree fatty acid receptor 4Homo sapiens (human)
white fat cell differentiationFree fatty acid receptor 4Homo sapiens (human)
brown fat cell differentiationFree fatty acid receptor 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of tasteFree fatty acid receptor 4Homo sapiens (human)
positive regulation of glucagon secretionFree fatty acid receptor 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeFree fatty acid receptor 4Homo sapiens (human)
negative regulation of somatostatin secretionFree fatty acid receptor 4Homo sapiens (human)
positive regulation of brown fat cell differentiationFree fatty acid receptor 4Homo sapiens (human)
positive regulation of cold-induced thermogenesisFree fatty acid receptor 4Homo sapiens (human)
cellular response to hormone stimulusFree fatty acid receptor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayFree fatty acid receptor 4Homo sapiens (human)
hormone secretionFree fatty acid receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityFree fatty acid receptor 1Homo sapiens (human)
lipid bindingFree fatty acid receptor 1Homo sapiens (human)
bioactive lipid receptor activityFree fatty acid receptor 1Homo sapiens (human)
G protein-coupled receptor activityFree fatty acid receptor 4Homo sapiens (human)
fatty acid bindingFree fatty acid receptor 4Homo sapiens (human)
taste receptor activityFree fatty acid receptor 4Homo sapiens (human)
peptide bindingFree fatty acid receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
lysosomal membraneFree fatty acid receptor 4Homo sapiens (human)
plasma membraneFree fatty acid receptor 4Homo sapiens (human)
ciliumFree fatty acid receptor 4Homo sapiens (human)
endosome membraneFree fatty acid receptor 4Homo sapiens (human)
endocytic vesicleFree fatty acid receptor 4Homo sapiens (human)
ciliary membraneFree fatty acid receptor 4Homo sapiens (human)
plasma membraneFree fatty acid receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1416221Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human FFA1 receptor expressed in Flp-In T-Rex 293 cells assessed as induction of Ca2+ mobilization after 45 mins by Fura2-AM dye-based fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
AID1416220Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human FFA4 receptor expressed in HEK293T cells assessed as induction of beta-arrestin-2 recruitment after 5 mins by BRET assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's4 (23.53)29.6817
2010's10 (58.82)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.89 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.88%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]